SBIR funding BioRankings has secured NIH SBIR grants (Phase I and Phase II) totaling substantial funding, indicating a successful track record with government-backed research projects and potential for continued funded collaborations or co-development opportunities.

Metabolomics focus Recent work includes untargeted metabolomics and detection software, suggesting strong capabilities in metabolomics data analysis that could be sold to biotech and pharma clients needing advanced metabolomics analytics or tool integration.

Multi-omics expertise Experience across microbiome, metabolomics, and streaming IoT data in medicine and manufacturing positions BioRankings as a versatile partner for life sciences firms pursuing integrated omics and real-time data solutions.

Strategic partnerships Recent collaboration with Domino Data Lab signals openness to platform partnerships and enterprise data science workflows, presenting a path to joint offerings or preferred provider arrangements for larger customers.

Small firm agility With a lean team and revenue under one million, BioRankings can be a compelling subcontractor or niche consultant for big pharma, biotech startups, or academic grants seeking specialized statistics, method development, and due diligence services.